PHAT - Phathom Pharmaceuticals to Participate in Upcoming Investor Conferences | Benzinga
FLORHAM PARK, N.J., Oct. 25, 2023 (GLOBE NEWSWIRE) -- Phathom Pharmaceuticals, Inc. (NASDAQ:PHAT), a biopharmaceutical company focused on developing and commercializing novel treatments for gastrointestinal diseases, announced today that members of its management team are scheduled to participate in the following investor conferences in November:
Guggenheim Securities 5th Annual Inflammation, Neurology & Immunology Conference in New York, NY
Date: Tuesday, November 7, 2023
Live Webcast: 2:30 p.m. ET
Management to participate in one-on-one meetings throughout the conference
Jefferies London Healthcare Conference in London, England
Date: Tuesday, November 14, 2023
Live Webcast: ...